Save the date for

2nd Annual Biosimilars LATAM

16th February - 17th February 2017

More about the Venue


Key topics

  • Clinical research aspects related to the register of a biosimilar in Brazil
  • Clinical challenges in biosimilar development
  • Access market strategies
  • Pharmacovigilance issues related to biosimilars
  • ANVISA's current regulation practices and its differences
  • Patient associations' perspective of biosimilars
  • Brand and pricing strategies to directly compete with biosimilars
  • The global context of biologics, biosimilars & biobetters
Special Features
  • Debate on pricing: Pharma vs. Patients
  • Real cases on biosimilar approval process
  • On-stage interview: Obstacles in the adoption of biosimilars in the healthcare system
  • Real-life case studies and interactive panel discussions

Want to know more?

Learn the full details about the event program in the downloadable agenda.

Who should attend

By position

MoBs, CxOs

VPs, Heads

Directors, Managers

By industry

  • biologics
  • biosimilars
  • biobetters
  • biotechnology
  • biotherapeutics
  • analytical science
  • process science
  • R&D
  • regulatory compliance
  • quality assurance
  • quality control
  • intellectual property
  • clinical immunology
  • scientific affairs
  • business development
  • portfolio planning
  • legal affairs
  • pharmacovigilance